TipRanks
Astellas Pharma Inc (ALPMF)
OTHER OTC:ALPMF
US Market
ALPMF
Astellas Pharma
RESEARCH TOOLSreports

Astellas Pharma (ALPMF) Ratios

58 Followers

Astellas Pharma Ratios

ALPMF's free cash flow for Q2 2026 was ¥0.74. For the 2026 fiscal year, ALPMF's free cash flow was decreased by ¥ and operating cash flow was ¥0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 26Mar 25Mar 24
Liquidity Ratios
Current Ratio
 ― 1.13 1.17 0.93 1.45
Quick Ratio
 ― 0.85 0.90 0.74 1.21
Cash Ratio
 ― 0.18 0.23 0.26 0.52
Solvency Ratio
 ― 0.14 0.28 0.09 0.22
Operating Cash Flow Ratio
 ― 0.19 0.46 0.13 0.45
Short-Term Operating Cash Flow Coverage
 ― 0.71 2.30 0.37 4.37
Net Current Asset Value
¥ ―¥ -624.94B¥ -314.24B¥ -778.88B¥ 101.39B
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.28 0.16 0.28 0.08
Debt-to-Equity Ratio
 ― 0.62 0.31 0.63 0.13
Debt-to-Capital Ratio
 ― 0.38 0.24 0.39 0.12
Long-Term Debt-to-Capital Ratio
 ― 0.27 0.15 0.22 0.03
Financial Leverage Ratio
 ― 2.21 1.95 2.24 1.63
Debt Service Coverage Ratio
 ― 1.60 1.92 0.39 2.47
Interest Coverage Ratio
 ― 14.46 29.83 19.01 32.51
Debt to Market Cap
 ― 0.33 0.13 0.31 0.04
Interest Debt Per Share
 ― 533.33 323.84 566.05 114.72
Net Debt to EBITDA
 ― 1.62 0.49 3.43 -0.74
Profitability Margins
Gross Profit Margin
―81.74%74.55%81.76%81.01%
EBIT Margin
―13.78%18.26%2.31%8.87%
EBITDA Margin
―24.19%27.36%12.18%15.83%
Operating Profit Margin
―13.37%19.62%11.10%18.80%
Pretax Profit Margin
―1.63%17.60%1.56%8.72%
Net Profit Margin
―2.65%13.63%1.06%6.50%
Continuous Operations Profit Margin
―2.65%13.63%1.06%6.50%
Net Income Per EBT
―162.46%77.42%68.26%74.58%
EBT Per EBIT
―12.22%89.73%14.02%46.37%
Return on Assets (ROA)
―1.52%8.17%0.48%4.02%
Return on Equity (ROE)
―3.35%15.92%1.07%6.55%
Return on Capital Employed (ROCE)
―11.22%17.87%7.80%16.49%
Return on Invested Capital (ROIC)
―9.98%12.52%4.39%11.70%
Return on Tangible Assets
―2.82%13.69%1.00%6.31%
Earnings Yield
―1.96%6.46%0.58%2.88%
Efficiency Ratios
Receivables Turnover
 ― 2.96 2.81 3.00 3.55
Payables Turnover
 ― 4.01 2.73 1.58 2.06
Inventory Turnover
 ― 1.17 1.64 1.18 1.65
Fixed Asset Turnover
 ― 5.81 5.97 5.46 5.30
Asset Turnover
 ― 0.57 0.60 0.45 0.62
Working Capital Turnover Ratio
 ― 78.46 12.46 13.77 5.42
Cash Conversion Cycle
 ― 343.07 217.98 201.06 146.09
Days of Sales Outstanding
 ― 123.34 129.97 121.76 102.86
Days of Inventory Outstanding
 ― 310.71 221.93 310.41 220.74
Days of Payables Outstanding
 ― 90.97 133.92 231.11 177.51
Operating Cycle
 ― 434.05 351.90 432.17 323.60
Cash Flow Ratios
Operating Cash Flow Per Share
 ― 112.62 316.15 96.18 180.09
Free Cash Flow Per Share
 ― 91.95 283.92 50.18 131.44
CapEx Per Share
 ― 20.67 32.23 46.00 48.65
Free Cash Flow to Operating Cash Flow
 ― 0.82 0.90 0.52 0.73
Dividend Paid and CapEx Coverage Ratio
 ― 1.21 2.92 0.87 1.74
Capital Expenditure Coverage Ratio
 ― 5.45 9.81 2.09 3.70
Operating Cash Flow Coverage Ratio
 ― 0.22 1.00 0.17 1.64
Operating Cash Flow to Sales Ratio
 ― 0.11 0.26 0.11 0.22
Free Cash Flow Yield
―6.36%11.27%3.06%6.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― 51.02 15.48 172.65 34.72
Price-to-Sales (P/S) Ratio
 ― 1.35 2.11 1.84 2.26
Price-to-Book (P/B) Ratio
 ― 1.71 2.46 1.84 2.27
Price-to-Free Cash Flow (P/FCF) Ratio
 ― 15.73 8.87 32.71 14.33
Price-to-Operating Cash Flow Ratio
 ― 12.84 7.97 17.06 10.46
Price-to-Earnings Growth (PEG) Ratio
 ― 0.26 0.03 -2.09 -1.81
Price-to-Fair Value
 ― 1.71 2.46 1.84 2.27
Enterprise Value Multiple
 ― 7.22 8.19 18.49 13.52
Enterprise Value
 ― 3.34T 4.80T 3.61T 3.25T
EV to EBITDA
 ― 7.22 8.19 18.49 13.52
EV to Sales
 ― 1.75 2.24 2.25 2.14
EV to Free Cash Flow
 ― 20.28 9.43 40.15 13.59
EV to Operating Cash Flow
 ― 16.56 8.47 20.95 9.92
Tangible Book Value Per Share
 ― -14.34 219.29 -154.20 339.03
Shareholders’ Equity Per Share
 ― 845.30 1.02K 889.98 828.54
Tax and Other Ratios
Effective Tax Rate
 ― -0.62 0.23 0.32 0.25
Revenue Per Share
 ― 1.07K 1.19K 894.27 834.40
Net Income Per Share
 ― 28.35 162.77 9.50 54.24
Tax Burden
 ― 1.62 0.77 0.68 0.75
Interest Burden
 ― 0.12 0.96 0.68 0.98
Research & Development to Revenue
 ― 0.17 0.15 0.18 0.18
SG&A to Revenue
 ― 0.44 0.40 0.46 0.42
Stock-Based Compensation to Revenue
 ― 0.00 0.00 0.00 0.00
Income Quality
 ― 3.97 1.94 10.12 2.48
Currency in JPY